Analysis of Nosocomial Infection and Risk Factors in Patients with ECMO Treatment

• Published in: Infection and drug resistance Vol. 14; pp. 2403 - 2410
• Main Authors: Li, Zhan-Jie, Zhang, Dong-Fang, Zhang, Wei-Hong
• Format: Journal Article
• Language: English
• Published: New Zealand Dove Medical Press Limited 01.01.2021; Taylor & Francis Ltd; Dove; Dove Medical Press
• Subjects: Acinetobacter baumannii; Antibacterial agents; Antibiotics; Carbapenems; Catheters; Drug resistance; Drug resistance in microorganisms; Extracorporeal membrane oxygenation; Gram-negative bacteria; Health aspects; Hospitals; Infection; infection site; Intubation; Medical colleges; Medical records; Medical research; Medicine, Experimental; Multivariate analysis; Nosocomial infection; Nosocomial infections; Original Research; Oxygenation; Pathogens; Patients; Respiratory tract diseases; Risk factors; Statistical analysis; Ventilators; China; Taiwan; infection site; risk factors; extracorporeal membrane oxygenation; nosocomial infection
• ISSN: 1178-6973; 1178-6973
• DOI: 10.2147/IDR.S306209

To investigate the drug resistance of nosocomial infection-related pathogens in patients who underwent extracorporeal membrane oxygenation (ECMO), analyzing the nosocomial infection-related risk factors. The medical records of 56 patients who received ECMO support treatment in the First Affiliated Hospital with Nanjing Medical University from January 2013 to December 2019 were selected. The nosocomial infection, pathogen distribution and drug resistance, and the influencing factors of nosocomial infection were analyzed. The predictive value of independent risk factors for nosocomial infection after ECMO was analyzed using the receiver operating characteristic (ROC) curve. A total of 56 patients receiving ECMO treatment were included. The nosocomial infection rate was 28.57%, and the prevalence infection rate was 44.64%. Lower respiratory tract infection was the main infection site. Among these infectious patients, 53 strains of pathogens were detected. The results showed that the gram-negative bacteria were mainly Acinetobacter baumannii and Klebsiella pneumonia. Moreover, the drug resistance rate of Acinetobacter baumannii to most of the antibiotics was more than 65%, among which the drug resistance rate to carbapenems was 80%. The results of risk factors of nosocomial infection after ECMO were analyzed by univariate analysis, showing that ECMO treatment time, hospitalization time, antibacterial drug use time, ventilator use time, catheter intubation time and central venous intubation time were statistically significant (all < 0.001). Multivariate analysis identified that ECMO treatment time was an independent risk factor. As showed by ROC curve, ECMO treatment time had a high predictive value for postoperative nosocomial infection. ECMO treatment times of more than 4.5 days were associated with an increased risk of nosocomial infection. The nosocomial infection rate after ECMO was relatively high, and the main pathogens are Gram-negative bacteria. The selection of antibiotics should be based on the results of pathogen drug sensitivity.